Intellia Therapeutics
NTLA
NTLA
144 hedge funds and large institutions have $635M invested in Intellia Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 53 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
3% less funds holding
Funds holding: 148 → 144 (-4)
Holders
144
Holding in Top 10
4
Calls
$2.01M
Puts
$1.32M
Top Buyers
| 1 | +$66.9M | |
| 2 | +$19.2M | |
| 3 | +$6.09M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.29M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.04M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$14.1M | |
| 3 | -$11.4M | |
| 4 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$6.76M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.6M |